Today on Medscape : Get the latest medical news, clinical trial coverage, drug updates, journal articles, CME activities & more on Medscape. A free resource for physicians.

  • 28articles · 30d
  • 3+ day agolatest article
  • Aug 17, 2026earliest in window
  • 100%with images
  • 318avg words
articles per day
Categories
  • Medical 25
  • Health & Wellness 25
  • Health 24
  • Arts, Culture, Entertainment & Media 1
  • Business & Industrial 1
  • Books & Literature 1
  • Crime & Law 1
  • Crime, Law & Justice 1

Please confirm you are human

This browser or connection looks automated. Press and continuously hold the control for 3 seconds to enable Google-hosted web results and, when separately allowed, AI-assisted answers.

A successful check enables 100 search requests. Interactive access does not authorize scraping, systematic collection, or reuse of search output.

Hold with a pointer, or hold Space or Enter.

News

Medscape
medscape.com > viewarticle > millions-adults-disabilities-have-lower-screening-rates-2026a1000xl9

Cancer Screening Lower for Adults With Disabilities

3+ day, 20+ hour ago   (739+ words) Rates of screening for breast, cervical, and colorectal cancers are lower among millions of US adults living with disabilities than among those without disabilities, according to a new study published in Cancer. “There are millions of individuals with disabilities who…...

Medscape
medscape.com > viewarticle > relapse-uncommon-after-surgery-appendiceal-cancer-2026a1000xjg

Relapse Uncommon After Surgery for Appendiceal Cancer

4+ day, 6+ hour ago   (433+ words) Medscape Relapse Uncommon After Surgery for Appendiceal Cancer Relapse after surgical resection of localized appendiceal adenocarcinoma was uncommon in a retrospective cohort study, occurring in 9.4% of patients at a median follow-up of 62.6 months. Relapse risk varied by histologic subtype, with…...

Medscape
medscape.com > viewarticle > mismatch-repair-deficiency-linked-improved-survival-2026a1000wp8

MMR Deficiency Tied to Better Survival in Gastric Cancer

6+ day, 22+ hour ago   (161+ words) In an analysis of patients with resectable oesophagogastric adenocarcinoma from two large trials, those with mismatch repair-deficient (MMRd) tumours treated with perioperative chemotherapy had significantly better survival than those with MMR-proficient (MMRp) tumours, and chemotherapy did not erase that advantage....